347640 <common-name>(5z)-3-benzyl-5-[[3-(4-ethoxy-3-nitrophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-3-benzyl-5-[[3-(4-ethoxy-3-nitrophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C28H22N4O4S2. With an average molecular weight of 542.60 g/mol, (5z)-3-benzyl-5-[[3-(4-ethoxy-3-nitrophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>623935-95-5</cas> <pubchem-id>5874424</pubchem-id> <chemical-formula>C28H22N4O4S2</chemical-formula> <weight>542.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:25:57Z</created-at> <updated-at type="dateTime">2026-08-31T11:25:57Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCOC1=C(C=C(C=C1)C2=NN(C=C2C=C3C(=O)N(C(=S)S3)CC4=CC=CC=C4)C5=CC=CC=C5)[N+](=O)[O-]</moldb-smiles> <moldb-formula>C28H22N4O4S2</moldb-formula> <moldb-inchi>InChI=1S/C28H22N4O4S2/c1-2-36-24-14-13-20(15-23(24)32(34)35)26-21(18-31(29-26)22-11-7-4-8-12-22)16-25-27(33)30(28(37)38-25)17-19-9-5-3-6-10-19/h3-16,18H,2,17H2,1H3/b25-16-</moldb-inchi> <moldb-inchikey>MTTLMGPEHBAYNM-XYGWBWBKSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">542.1082475</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343533</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-3-benzyl-5-[[3-(4-ethoxy-3-nitrophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0297979</sync-id> <structure-inchikey>MTTLMGPEHBAYNM-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>80024000000000000000000000000000010000040000000040400200002010000000200000200400000000400000000080100000000000000000000000000008000000000000002000001000030000180000000040000000000000000000020000010011800080000800010010804000000000000000000000c1c0200000800000000000000000800000001100000000020000000400000000000000000000000000080000000000000020090000020200040000000000000000000000000001000000000000000010000000040000000220040000000000000040000000000040000000800000000000081020000000000200000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMGAGAAAAAC AggAKAAAAAMCBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEBkBo AAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQHQCgAAAADAwdAKAAAAAMDBkBoAAAA AwMBBkAoAAAAAwQGAGgAAAADAwEGACgAAAADBAYAKAAAAAMECAAoAAAAAwIH ACgAAAADAwYAKAAAAAMEEAAoAAAAAwIQACAAAAACBgBgAAAAAgIGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMD AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkBoAAAAAwMBByAqAAAAAQMECAAoAAAAAwIIICoAAAD/AwELAAEAAQIAAgMg AwRoDAQFaAwFBmgMBgdoDAcIaAwGCSAJCmgMCgtoDAsMaAwMDWgMDQ4gDg8o Ag8QIBARKAIQEiASEyATFCgCExUAEhYAFhcAFxhoDBgZaAwZGmgMGhtoDBsc aAwLHSAdHmgMHh9oDB8gaAwgIWgMISJoDAQjICMkKAIjJSAIA2gMDQloDBUP ABwXaAwiHWgMQgUAAAAGAwgHBgUEBQoJDQwLBRAPFRMSBhgZGhscFwYeHyAh Ih0XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:11Z</structure-indexed-at> </compound>